We are live on ! Find out more
OMC

Overbrook Management Corp Portfolio holdings

AUM $663M
1-Year Est. Return 35.04%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+35.04%
3 Year Est. Return
+145.9%
5 Year Est. Return
+162.55%
10 Year Est. Return
+621.18%
AUM
$382M
AUM Growth
+$37.7M
Cap. Flow
+$26M
Cap. Flow %
6.8%
Top 10 Hldgs %
57.03%
Holding
85
New
5
Increased
9
Reduced
41
Closed
9

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$14.7M
2
KEYS icon
Keysight
KEYS
+$8.95M
3
AMD icon
Advanced Micro Devices
AMD
+$8.11M
4
VRSN icon
VeriSign
VRSN
+$7.32M
5
BAC icon
Bank of America
BAC
+$6.88M

Sector Composition

Rank Sector Weight
1 Technology 28.14%
2 Financials 20.03%
3 Healthcare 17.31%
4 Communication Services 12.61%
5 Consumer Discretionary 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$136B
$398K 0.1%
5,740
MDY icon
52
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$394K 0.1%
860
BKLN icon
53
Invesco Senior Loan ETF
BKLN
$6.78B
$391K 0.1%
18,822
-611
-3% -$12.8K
PEP icon
54
PepsiCo
PEP
$193B
$379K 0.1%
2,081
PFE icon
55
Pfizer
PFE
$159B
$379K 0.1%
9,277
-2,851
-24% -$123K
ISEE
56
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$365K 0.1%
15,000
VOO icon
57
Vanguard S&P 500 ETF
VOO
$1.03T
$360K 0.09%
956
MS icon
58
Morgan Stanley
MS
$337B
$330K 0.09%
3,764
BSV icon
59
Vanguard Short-Term Bond ETF
BSV
$45.6B
$320K 0.08%
4,185
-300
-7% -$22.7K
MCD icon
60
McDonald's
MCD
$188B
$308K 0.08%
1,100
-100
-8% -$26.8K
TMO icon
61
Thermo Fisher Scientific
TMO
$230B
$303K 0.08%
525
-50
-9% -$28.2K
VUG icon
62
Vanguard Morningstar Growth ETF
VUG
$228B
$288K 0.08%
6,936
-210
-3% -$8.17K
CLDX icon
63
Celldex Therapeutics
CLDX
$3.07B
$279K 0.07%
7,763
-312
-4% -$13.5K
GLD icon
64
SPDR Gold Trust
GLD
$149B
$278K 0.07%
1,515
PG icon
65
Procter & Gamble
PG
$334B
$261K 0.07%
1,756
IJT icon
66
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.08B
$220K 0.06%
2,000
FIVE icon
67
Five Below
FIVE
$13.4B
$206K 0.05%
+1,000
New +$197K
GBDC icon
68
Golub Capital BDC
GBDC
$3.38B
$205K 0.05%
15,102
-1
-0% -$13
VHT icon
69
Vanguard Health Care ETF
VHT
$19.3B
$203K 0.05%
850
SYK icon
70
Stryker
SYK
$127B
$201K 0.05%
+705
New +$187K
CSBR icon
71
Champions Oncology
CSBR
$68.5M
$195K 0.05%
48,488
-5,400
-10% -$23.1K
ICCC icon
72
ImmuCell
ICCC
$90.3M
$168K 0.04%
32,857
-2,675
-8% -$17.4K
DUOT icon
73
Duos Technologies
DUOT
$294M
$130K 0.03%
46,563
-11,579
-20% -$42.1K
IA
74
Innovative Solutions & Support
IA
$370M
$107K 0.03%
14,575
STRM
75
DELISTED
Streamline Health Solutions
STRM
$51.8K 0.01%
1,917
-1
-0.1% -$28

Similar funds

Overbrook Management Corp's Q1 2023 Portfolio in Review

As of Q1 2023, Overbrook Management Corp held 85 positions worth $382M, up 11% from $344M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Overbrook Management Corp deployed $26M of net new capital in Q1 2023, opening 5 new positions and adding to 9 existing holdings. Its largest new stake was Uber: 464,162 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P Oil & Gas Exploration & Production ETF, an estimated $3.15M trimmed.

  • Overbrook Management Corp's largest Q1 2023 buy was Uber: 464,162 shares worth $14.7M.
  • Overbrook Management Corp added most to VeriSign in Q1 2023, an estimated $7.32M increase.
  • Overbrook Management Corp's biggest Q1 2023 reduction was State Street SPDR S&P Oil & Gas Exploration & Production ETF, cutting an estimated $3.15M.
  • Overbrook Management Corp fully exited PayPal in Q1 2023, selling an estimated $9.93M.
  • Overbrook Management Corp's ten largest holdings make up 57% of its $382M portfolio in Q1 2023.
  • Overbrook Management Corp opened 5 new positions and closed 9 in Q1 2023.
  • Overbrook Management Corp's portfolio value rose 11% quarter-over-quarter to $382M.

Based on Overbrook Management Corp's 13F filing for Q1 2023, filed 12 May 2023.